Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 22653056)

1.

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.

Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG, Ferrara N, Sofroniew MV, John GR.

J Clin Invest. 2012 Jul;122(7):2454-68. doi: 10.1172/JCI60842. Epub 2012 Jun 1.

2.

IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.

Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR.

J Immunol. 2006 Oct 15;177(8):5574-84.

3.

CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.

Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, Pirko I, Seroogy KB, Johnson AJ.

J Immunol. 2010 Jan 15;184(2):1031-40. doi: 10.4049/jimmunol.0902773. Epub 2009 Dec 11.

4.

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.

Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1977-82. doi: 10.1073/pnas.0808698106. Epub 2009 Jan 27.

5.

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.

Wosik K, Cayrol R, Dodelet-Devillers A, Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL, Prat A.

J Neurosci. 2007 Aug 22;27(34):9032-42.

6.

Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?

Feng S, Huang Y, Chen Z.

Med Hypotheses. 2011 May;76(5):618-21. doi: 10.1016/j.mehy.2010.12.001. Epub 2011 Mar 12.

PMID:
21398042
7.
8.

Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.

Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M.

J Cereb Blood Flow Metab. 2007 Oct;27(10):1684-91. Epub 2007 Mar 14.

9.

Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

Chapouly C, Tadesse Argaw A, Horng S, Castro K, Zhang J, Asp L, Loo H, Laitman BM, Mariani JN, Straus Farber R, Zaslavsky E, Nudelman G, Raine CS, John GR.

Brain. 2015 Mar 23. pii: awv077. [Epub ahead of print]

PMID:
25805644
10.

Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.

Suidan GL, Dickerson JW, Johnson HL, Chan TW, Pavelko KD, Pirko I, Seroogy KB, Johnson AJ.

J Neuroinflammation. 2012 Sep 18;9:218. doi: 10.1186/1742-2094-9-218.

11.

Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.

Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z.

PLoS One. 2011;6(8):e20599. doi: 10.1371/journal.pone.0020599. Epub 2011 Aug 17. Erratum in: PLoS One. 2011;6(8). doi: 10.1371/annotation/716c0fb2-dbdd-4da5-ad8a-d2b1cdac4ec6.

12.

SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.

Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ, Kim KW.

Nat Med. 2003 Jul;9(7):900-6.

PMID:
12808449
13.

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.

Göbel K, Pankratz S, Schneider-Hohendorf T, Bittner S, Schuhmann MK, Langer HF, Stoll G, Wiendl H, Kleinschnitz C, Meuth SG.

J Autoimmun. 2011 Mar;36(2):106-14. doi: 10.1016/j.jaut.2010.11.004. Epub 2011 Jan 8.

PMID:
21216565
14.

Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner.

Sonobe Y, Takeuchi H, Kataoka K, Li H, Jin S, Mimuro M, Hashizume Y, Sano Y, Kanda T, Mizuno T, Suzumura A.

J Biol Chem. 2009 Nov 13;284(46):31834-42. doi: 10.1074/jbc.M109.025940. Epub 2009 Sep 23.

15.

Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats.

Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ.

J Neuropathol Exp Neurol. 2002 Oct;61(10):914-25.

PMID:
12387457
16.

eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.

Di Lorenzo A, Lin MI, Murata T, Landskroner-Eiger S, Schleicher M, Kothiya M, Iwakiri Y, Yu J, Huang PL, Sessa WC.

J Cell Sci. 2013 Dec 15;126(Pt 24):5541-52. doi: 10.1242/jcs.115972. Epub 2013 Sep 17. Erratum in: J Cell Sci. 2014 May 1;127(Pt 9):2120.

17.

Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis.

Basivireddy J, Somvanshi RK, Romero IA, Weksler BB, Couraud PO, Oger J, Kumar U.

Biochem Pharmacol. 2013 Aug 15;86(4):497-507. doi: 10.1016/j.bcp.2013.06.001. Epub 2013 Jun 13.

PMID:
23770458
18.
19.

The role of eNOS in vascular permeability in ENU-induced gliomas.

Bulnes S, Argandoña EG, Bengoetxea H, Leis O, Ortuzar N, Lafuente JV.

Acta Neurochir Suppl. 2010;106:277-82. doi: 10.1007/978-3-211-98811-4_52.

PMID:
19812964
20.

Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown.

Füchtbauer L, Toft-Hansen H, Khorooshi R, Owens T.

J Mol Neurosci. 2010 Sep;42(1):89-98. doi: 10.1007/s12031-010-9371-8. Epub 2010 Apr 23.

PMID:
20414743
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk